Living Cell Technologies Ltd. ADR | |
Stock Exchange | Other OTC |
EPS |
$0.01 |
Market Cap |
$10.29 M |
Shares Outstanding |
57.14 M |
Public Float |
- |
Living Cell Technologies Ltd. | |
Stock Exchange | Other OTC |
EPS |
- |
Market Cap |
$9.71 M |
Shares Outstanding |
571.44 M |
Public Float |
- |
Living Cell Technologies Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0 |
Market Cap |
AUD13.14 M |
Shares Outstanding |
571.44 M |
Public Float |
453.68 M |
Living Cell Technologies Ltd. | |
Stock Exchange | Boerse Berlin |
EPS |
- |
Market Cap |
EUR42.86 M |
Shares Outstanding |
571.44 M |
Public Float |
- |
Address |
Hunters Corner Auckland AU 2155 New Zealand |
Employees | - |
Website | http://www.lctglobal.com |
Updated | 07/08/2019 |
Living Cell Technologies Ltd. is a biotechnology company, engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. The company was founded by Robert Bartlett Elliot and David Collinson in 1987 and is headquartered in Auckland, New Zealand. . |